An overview is given of the primary basis for the scientific inference that somidobove sustained release injection is safe for multiparous dairy cows. The process of analysis and interpretation of the voluminous data collected from a target animal safety study which started with 28 cows and lasted two lactations is described.
INTRODUCTION
Obtaining Food and Drug Administration approval to sell a nevi product to U. S. dairymen to increase efficiency of milk production requires, inter alia, that its use be shown to be safe to dairy co,,'s. A key element in the process of demonstrating safety of an animal drug is a safety study in the species for which the product is intended to be used.
Target animal safety studies (TASS) are usually designed such that three groups of animals treated with the drug at IX, 3X, and 5X the intended use level are compared to an untreated control group.
The intent is to determine whether the efficacious, recommended use level OX) causes adverse effects. The 5X
level should identify variables of greatest sensitivity to toxicologic impact and allow an estimate of the magnitude of the toxicity.
The 3X
level improves the chances of achieving both objectives.
II. MATERIAL AND METHODS
In order to provide an in-depth safety profile for somidobove, a form of bovine somatotropin produced by recombinant DNA technology, a TASS was conducted with the product on 28 multiparous dairy cattle under simulated field use conditions during two consecutive lactations. Individual animal (quantitative) response observations were determined for 60 variables ( Table 1 ) at frequencies that varied from twice daily (yield milk) to once every three months (milk phosphorus concentration).
These attributes together with the biologists' preference for univariate tests at each sampling in time, over multivariate t)~e analyses, made summarization and analysis a challenge. INTRODUCTION Obtaining Food and Drug Administration approval to sell a nevi product to U. S. dairymen to increase efficiency of milk production requires, inter alia, that its use be shown to be safe to dairy co,,'s. A key element in the process of demonstrating safety of an animal drug is a safety study in the species for which the product is intended to be used.
These attributes together with the biologists' preference for univariate tests at each sampling in time, over multivariate t)~e analyses, made summarization and analysis a challenge. Dropouts from multilactation dairy trials are unavoidable; this complicated analysis.
To focus attention on variables affected by treatment, to avoid missing potential problems, and yet to keep analysis understandable, we utilized the two types of analyses --wi thin lactation and lactations combined --described below.
Within Lactations
Somidobove was injected subcutaneously every 28 days for 10 consecutive treatments; 36 variables were measured in blood samples collected every 28 days.
For a large majority of the variables, summarization of the data by 28-day period means allowed treatment effects within a single lactation to be evaluated.
To identify variables most sensitive to somidobove over time within each lactation, the following statistical screen devised in consultation ,,"ith the FDA Center for Veterinary Medicine personnel was implemented. Forty variables either observed every 28 days, or summarized on a 28-day basis, were analyzed by the following model: To focus attention on variables affected by treatment, to avoid missing potential problems, and yet to keep analysis understandable, we utilized the two types of analyses --wi thin lactation and lactations combined --described below.
To identify variables most sensitive to somidobove over time within each lactation, the following statistical screen devised in consultation ,,"ith the FDA Center for Veterinary Medicine personnel was implemented. Forty variables either observed every 28 days, or summarized on a 28-day basis, were analyzed by the following model: lactation 1  lactation 2  Source  df  df   Treatment  3  3  Cows (treatment)  24  19  Period  9  9  Treatment x period  27  27  Error  205  163 This analysis was appropriately modified for variables observed every three months within each lactation.
Furthermore, treatment x period effect was partitioned into three component effects:
• control vs 960 mg x period
• control vs 2880 mg x period
• control vs 4800 mg x period
In this model, period was a repeated measures effect and treatment x period effect reflected changes that occur in treatment effects over time during the lactation. Concatenation of period mean values over two lactations onto one graph provided an effective way to visually demonstrate the exquisite sensitivity of this screen (Figure 1 ).
Lactations Combined
To satisfy the second objective of determining long-term administration (two lactation) effects, all observations for a variable during each lactation were averaged into a single value.
Lactation summary values were the observations employed in this statistical analysis to estimate response to treatments. Lactation was a repeated measures effect in the statistical model The treatment x lactation interaction effect reflected changes that may occur in treatment effect from the first to the second lactation.
Cows (treatment) was the error term for testing treatment effects and contrasts in this model.
In this TASS sixty quanti tati ve variables (Table 1 ) required analysis. Fisher (1937) discussed analysis of variance CANOVA) in the context of one or perhaps only a few variables.
Consequently, to avoid being misled by random chance variation, a global view of the study was needed.
To do this, a p-value plot of all variables collected, a technique exemplified by Schweder and Spj otvoll (1982) , was used.
Theory says that in a p-value plot of ANOVA p-values all points corresponding to true null hypotheses should approximate a straight line, while those representing false null hypotheses should deviate from the line. The line can, therefore, be used to estimate the number of true null hypotheses.
Two biologically similar measures like MeR and MCV are statistically independent enough in realiza~ tion, i.e. measurement error, for the approach to be practical in a multivariable TASS.
This approach was applied separately first to test treatment x lactation ( Figure 5) , and also to all three contrasts of primary interest (control vs 960 mg group, control vs 2880 mg group, and control vs 4800 mg group).
III. RESULTS A1~ DISCUSSION

Within Lactations
A variable adversely affected by somidobove over time would exhibit a profile not parallel to that of the control. A sensitive indicator of this non-parallelism (i.e. variables that increase as well as those that 36 the lactation.
Concatenation of period mean values over two lactations onto one graph provided an effective way to visually demonstrate the exquisite sensitivity of this screen (Figure 1 ).
Lactations Combined
III. RESULTS A1~ DISCUSSION
Within Lactations
A variable adversely affected by somidobove over time would exhibit a profile not parallel to that of the control. A sensitive indicator of this non-parallelism (i.e. variables that increase as well as those that decrease compared to control) was provided by the treatment contrast by period interaction.
A significant contrast x period interaction selected variables in need of biological evaluation; if significance occurred for any variable for any of these interactions for either first or second lactation, then graphs of treatment x period least squares means ± standard error for the affected variable were made to assist in a biological evaluation of the finding.
An example analysis of variance with treatment contrast by period interactions highlighted is in Table 2 .
A summary of contrast p-values is shown in Table 3 ; graphs for a selected few variables appear in Figures 1 -4 .
Making a complete graphic necessitated 'pretreatment' or covariate least squares mean values be plotted as period/month 0 (beginning of lactation 1) and 15 (beginning of lactation 2).
These means ± standard errors were obtained by reapplying a similar analysis to a dataset restricted to consist of observations obtained at these times.
Statistical science is a powerful aid to inference not a panacea.
The error terms used in the above statistical screen are auto-correlated ones, known to be too small, and thus prone to give false signals that something other than random variability has influenced the result. They have 205 and 163 degrees of freedom in lactation 1 and 2, respectively, and are compiled from repeated measures over time from the same individual; "statistically" independen t they may be, "biologically" independent they are not. Greenhouse and Geisser (1959) suggested making the test with degrees of freedom divided by the number of periods less one to reduce spurious significance. Conversely, Huynh and Feldt (1970) showed these tests were valid F-statistics (with a df multiplier (£) equal to one) if, and only if, all possible time differences x.-x.
(i~j) are equally variable.
Homeostatic TASS variables over time l appear to be a tailor-made example requiring no £ correction to be made.
A 'significant' (p<. 002) control vs 2880 mg x period value for aspartate transaminase (AST) , in lactation 1 (Tables 2 and 3, Figure 1 ) draws attention to the different amount of white space between the two relevant bounds over periods.
In particular, none prior to period 4, a noticeable amount for one period, and then a small amount for the remainder of lactation 1. Failure of the finding to repeat in lactation two or for the 4800 mg contrast to reinforce the finding make it less than compelling.
Borderline significance occurred on two occasions for Albumin/Globulin (A/G) ratio for control vs 2880 mg x period (Table 3, Figure 2 ).
Evidently, the test was highly sensitive to idiosyncrasy in the crossingover patterns of the two bounds. The finding was not repeated for 4800 mg despite an equally disparate set of bounds; and the more reason why borderline significance (p~.05) on a single occasion is shaky statistical grounds for a claim that something other than random variability has influenced the result.
Systematic scrutiny of the plots of the 19 variables that had at least one significant contrast interaction listed in Table 3 identify only somidobove level in the blood CBST) and the erythrocytic variables to be showing more than random variation during somidobove treatment.
Somidobove level in 37 decrease compared to control) was provided by the treatment contrast by period interaction. A significant contrast x period interaction selected variables in need of biological evaluation; if significance occurred for any variable for any of these interactions for either first or second lactation, then graphs of treatment x period least squares means ± standard error for the affected variable were made to assist in a biological evaluation of the finding.
The error terms used in the above statistical screen are auto-correlated ones, known to be too small, and thus prone to give false signals that something other than random variability has influenced the result. They have 205 and 163 degrees of freedom in lactation 1 and 2, respectively, and are compiled from repeated measures over time from the same individual; "statistically" independen t they may be, "biologically" independent they are not.
Greenhouse and Geisser (1959) suggested making the test with degrees of freedom divided by the number of periods less one to reduce spurious significance. Conversely, Huynh and Feldt (1970) showed these tests were valid F-statistics (with a df multiplier (£) equal to one) if, and only if, all possible time differences x.-x.
Somidobove level in blood tended to increase with time during the first lactation but not during the second lactation.
Erythrocytic Variables: Contrasts of control vs. 2880 X period and control vs. 4800 X period were consistently at or below a probability of 0.01 for mean corpuscular volume (MCV) and mean corpuscular hemoglobin (riCR) in both Lactations 1 and 2 (Table 1 ). In addition, contrasts of control vs 4800 X period for erythrocyte count were significant (P=.05) in Lactation 2 only (Table 3) . None of the six contrasts is significant for either packed cell volume (PCV) or hemoglobin concentration (HGB).
Changes in erythrocytic variables are generally interrelated.
Therefore, any changes in erythrocyte count, hemoglobin concentration and PCV should affect the MCV and MCR values as well.
But in this interaction screen confidence bounds for MeV (Figure 3 ) and MCH ( Figure 4) were less parallel over the lactation than the corresponding ones for pev and RGB.
The slight changes in MeV and MeR in the absences of corresponding changes in other erythrocytic variables may be explained by the fact that long-term intramuscular or subcutaneous administration of a compound often causes minor inflammatory reactions at the injection sites.
Observation of dose-related minor irritation at the injection sites in this study was the case.
It is known that any inflammatory reaction will perturb erythropoiesis resulting in production of red cells with reduced MeV and MeR (Jain, 1968) .
Fluctuation in erythrocytic variables is reported to be common in bovine species during the first few years of life before becoming stabilized (Jain, 1986) .
High producing cows often have lower hemoglobin concentration than low producing cows (Whitlock et a1., 1974 A sample of analysis of variance for data ""ith lactations combined is in Table 4 .
The variable is calving interval and p-values for treatment x lactation, control vs 4800 mg, and control vs 960 mg appear in Figures 5, 6 , and 7, respectively. Lactation x Somidobove Level: Figure 5 shows a p-value plot of all tests of Treatment x Lactation effect for multiparous cows.
The plot shows excellent conformity with a "45 0 line plot". Such agreement indicated the experiment viewed as a whole provides no evidence that treatment effects for cows are different in the two lactations tested.
The p-value plot technique isolated easily the following situation which has a ready explanation for why it is "unusual".
Mean birth weights in lbs of calvings by lactation and multiplicity were: 38 blood tended to increase with time during the first lactation but not during the second lactation.
Erythrocytic Variables:
Contrasts of control vs. 2880 X period and control vs. 4800 X period were consistently at or below a probability of 0.01 for mean corpuscular volume (MCV) and mean corpuscular hemoglobin (riCR) in both Lactations 1 and 2 (Table 1 ). In addition, contrasts of control vs 4800 X period for erythrocyte count were significant (P=.05) in Lactation 2 only (Table 3) . None of the six contrasts is significant for either packed cell volume (PCV) or hemoglobin concentration (HGB).
High producing cows often have lower hemoglobin concentration than low producing cows (Whitlock et a1., 1974) . A sample of analysis of variance for data ""ith lactations combined is in Table 4 .
Mean birth weights in lbs of calvings by lactation and multiplicity were: 
Numbers in parentheses indicate numbers of births.
Somidobove at 960 mg appears to have no detrimental effect on calf weight. It may appear prudent to draw the inference from this table that the 4800 mg level begins to impact calf weight in the second lactation. An alternative simple explanation is by chance more twins Ylere in the 4800 mg group; all that is being detected is that twins are smaller and weigh less than calves of single births.
Control vs 4800 mg somidobove: Figure 6 shows the classic "two intersecting lines" pattern; the intersection point provides a good cut-point or signal of variables affected by the 4800 mg somidobove level. Indeed scientific evaluation needs to focus only on variables listed above where two lines intersect (albumin globulin ratio, AG_RA); only they exhibit contrast probabilities that are beyond chance expectation under the null hypothesis.
Control vs 960 mg somidobove:
The two-lactation average milk production increase estimate due to 960 mg is a respectable 2.43 kg/day (P level = .22); small sample size and an imbalanced sample have likely contributed to the non-significance of this result. Figure 7 shows the p-value plot for control vs ':;lOU mg som~aoDove.
This plot shows 960 mg somidobove to be without effect on the 60 variables tested.
IV. CONCLUSIONS
The auto-correlated error used to signal treatment effects over time in the within-lactation analyses gave many false positive signals; the plots of means over time ± standard error bounds, p~value magnitude and biological knowledge easily screened out such 'spurious' significances.
This small two lactation study confirms that somidobove increases fat corrected milk and milk yield.
In cows, the 4800 mg level produces yield effects in the 4-5 kg/day range; the quality of milk was unaffected. Increased milk production evidently stimulates a corresponding small 
Control vs 960 mg somidobove:
IV. CONCLUSIONS
In cows, the 4800 mg level produces yield effects in the 4-5 kg/day range; the quality of milk was unaffected. Increased milk production evidently stimulates a corresponding small increase in dry matter intake.
When this is not sufficient to sustain all the increased production, body-fat stores are utilized.
Rate of weight gain and average body weight all reflect this self-limiting process; cows on 960 -4800 mg somidobove weighed about 25 kg less at the end of their lactations than did comparable controls.
At the highest level of somidobove (4800 mg) clinical chemistry and hematology variables affected were blood urea nitrogen, total protein, globulin, albumin globulin ratio, mean corpuscular volume, thrombocytes, mean corpuscular hemoglobin, packed cell volume, hemoglobin and eosinophils. The low level (960 mg) showed no effect on these variables.
A review of all the variables 'V"hich were tested in this study did not reveal any biologically significant changes that would preclude the safe use of somidobove in multiparous dairy cows. increase in dry matter intake.
A review of all the variables 'V"hich were tested in this study did not reveal any biologically significant changes that would preclude the safe use of somidobove in multiparous dairy cows. Ilounds for the treatments ore ledst squares means + or -SID Error. Period/Month. Period/l.lonth. ;:3 g, 
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